Mikie Sherrill bought Bristol-Myers Squibb Company (NYSE: BMY)
Mikie Sherrill (D-NJ), a U.S. Representative, has disclosed 4 trades in Bristol-Myers Squibb Company (BMY) since 2019, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Mikie Sherrill bought $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on July 25, 2019. Since that trade, BMY is up +79.42% against the S&P 500 up +168.62%, an outperformance of -89.19%.
Across these filings, Mikie Sherrill has been a balanced trader of BMY (a buy-to-sell ratio of 1.00). The most recent disclosed BMY transaction shown was dated February 20, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Mikie Sherrill's BMY trades vs the price
BMY is up +79.42% since Mikie Sherrill bought on July 25, 2019, versus +168.62% for the S&P 500.
Performance since this trade
All Mikie Sherrill BMY trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| February 20, 2020 | SELL | $51.27 | +23.08% | — | |
| January 21, 2020 | BUY | $53.04 | +18.96% | -$514 | |
| December 18, 2019 | SELL | $49.33 | +27.92% | — | |
| July 25, 2019 | BUY | $35.17 | +79.42% | +$3K |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Mikie Sherrill & BMY trading FAQ
Is it legal for Mikie Sherrill to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mikie Sherrill buy BMY?
Mikie Sherrill disclosed a purchase of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on July 25, 2019, according to public STOCK Act filings.
How has BMY performed since Mikie Sherrill's trade?
Since Mikie Sherrill bought BMY on July 25, 2019, the stock is up +79.42%, versus +168.62% for the S&P 500 over the same period, an outperformance of -89.19%.
How many times has Mikie Sherrill traded BMY?
Mikie Sherrill has disclosed 4 BMY trades since 2019 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Mikie Sherrill's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyMikie Sherrill's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.